ViiV forms public-private partnership for pediatric HIV research

ViiV Healthcare Ltd. announced a public-private partnership with the Clinton Health Access Initiative and Mylan Inc. (NASDAQ:MYL) to develop a dispersible formulation of a fixed dose combination of HIV drug abacavir/lamivudine for pediatric use in resource-limited settings. ViiV will fund clinical development and regulatory activities, while Mylan will submit regulatory applications and support production and distribution of the product. The deal is the first under a 2010 memorandum of understanding between ViiV and the initiative to collaborate on pediatric HIV. ...